98%
921
2 minutes
20
This study aimed to translate the EORTC QLQ-OPT30 into Mandarin (Simplified) Chinese and assess its reliability, validity, and acceptability among Chinese uveal melanoma (UM) patients. From January 2023 to June 2024, 60 UM patients from a tertiary hospital in central China were enrolled. The process involved both forward and back translation to develop the Mandarin (Simplified) Chinese version of the EORTC QLQ-OPT30. Statistical analyses were conducted using SPSS 25.0. Reliability was evaluated using Cronbach's α coefficient, and validity was assessed through factor analysis and Pearson correlation tests. Acceptability was determined based on response rate and average completion time. The EORTC QLQ-OPT30 module contains 26 items for all patients, with an additional 4 items for those undergoing treatments other than enucleation. The module measures various aspects such as ocular irritation, visual impairment, headaches, concerns about disease recurrence, appearance issues, functional problems related to vision impairment, reading difficulties, functional issues in the treated eye, and driving problems. The study included 60 patients (45% male, 55% female) with an average age of (55.22 ± 10.02) years. The internal consistency reliability of the multi-item scales was acceptable, with Cronbach's α values ranging from 0.848 to 0.946, except for the AP dimension, which had a lower α value of 0.567. The Mandarin (Simplified) Chinese version of the EORTC QLQ-OPT30 was tested in internal consistency, the split-half, and retest reliability, along with structural, convergent, and discriminant validity; as well as acceptability by its effectiveness, all the above demonstrated good values, making it a valuable tool for measuring health-related quality of life in Chinese UM patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12222855 | PMC |
http://dx.doi.org/10.1038/s41598-025-06423-w | DOI Listing |
Sci Rep
July 2025
Department of Nursing, Henan Provincial Intelligent Nursing and Transformation Engineering Research Center, Henan Provincial Key Medicine Laboratory of Nursing, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
This study aimed to translate the EORTC QLQ-OPT30 into Mandarin (Simplified) Chinese and assess its reliability, validity, and acceptability among Chinese uveal melanoma (UM) patients. From January 2023 to June 2024, 60 UM patients from a tertiary hospital in central China were enrolled. The process involved both forward and back translation to develop the Mandarin (Simplified) Chinese version of the EORTC QLQ-OPT30.
View Article and Find Full Text PDFBMC Psychiatry
November 2024
Psychology Institute, Psychopathology and Health Process Laboratory UR4057 ED 261, Paris City University, Boulogne-Billancourt, France.
Background: Quality of life (QoL) in patients undergoing surveillance for uveal melanoma (UM) can be affected by psychological sequelae. Fear of cancer recurrence (FCR) may be acute especially when prognostication indicates an increased risk of metastatic recurrence. Communication with an ophthalmologist or oncologist can then play a key role in impacting QoL.
View Article and Find Full Text PDFRadiat Oncol
September 2021
Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Background: Proton beam therapy is a well-established treatment option for patients with uveal melanoma (UM). The treatment procedure, in general, includes placing radiopaque clips to ensure exact eye-positioning during radiotherapy, followed by the delivery of proton irradiation. The short-term burden associated with proton therapy in patients with UM has rarely been addressed.
View Article and Find Full Text PDFOcul Oncol Pathol
May 2020
Department of Surgery, Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Background: Patients with uveal melanoma (UM) are known to have quality of life (QOL) issues after treatment, but QOL concerns after initial diagnosis are ill-defined.
Objectives: We studied the QOL concerns of patients with UM after initial diagnosis to identify factors associated with QOL.
Method: Between September 2011 and May 2016, UM planning to undergo radiotherapy completed the European Organization for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ)-C30, as well as the Ophthalmic Oncology module, QLQ-OPT30.
Ocul Oncol Pathol
March 2020
Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Background: Uveal melanoma and its treatment can influence the physical and psychological well-being of patients in a way that differs from other cancers. Factors influencing quality of life (QOL) include visual impairment, changes in appearance, day-to-day functioning, ocular discomfort, and worry regarding disease recurrence.
Objective: We aimed to study both general and disease-specific QOL in uveal melanoma patients in Ireland and compare QOL between a plaque radiotherapy group and an enucleation treatment group.